MCMingjie Chen

Mingjie Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mingjie Chen has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Differentiation of non-hypervascular non-functional pancreatic neuroendocrine neoplasms from solid pseudopapillary neoplasms using dual-layer spectral detector CT

    by Jiaxin Yuan, Mingjie Chen, Jiawei Liu, Liqin Wang, Minghao Zhang, Ning Zhang, Shi-Ting Feng, Luyong Wei, Siya Shi, Yanji Luo

    Dual-layer spectral detector CT (DLCT) represents an advanced and emerging modality in CT imaging, offering multiparametric images that enhance the quantitative assessment of pancreatic diseases. Non-hypervascular non-functional pancreatic neuroendocrine neoplasms (NF-pNENs) and solid pseudopapillary neoplasms (SPNs) frequently exhibit overlapping clinical and imaging features, complicating their differentiation. This study aimed to investigate the valuable quantitative parameters of DLCT in preoperative differentiation between non-hypervascular NF-pNEN and SPN, as well as to analyze their diagnostic performance. This retrospective study included 52 patients with pathologically confirmed non-hypervascular NF-pNENs and SPNs who underwent DLCT examination before surgery between June 2019 and September 2025. To differentiate between non-hypervascular NF-pNENs and SPNs, independent relevant clinical-radiological features and quantitative parameters were identified using the Least Absolute Shrinkage and Selection Operator (LASSO) regression analysis and multivariate logistic regression analysis. The diagnostic performances of independent variables were assessed through receiver operating characteristic curves. There were 34 patients with non-hypervascular NF-pNENs (46.7 ± 10.2 years, 19 females) and 18 patients with SPNs (32.8 ± 7.9 years, 14 females). Clinical, radiological features and parameters were evaluated with near-perfect agreements among two radiologists. Age and normalised iodine concentration of lesion in the arterial phase (nICa) were the independent factors for differentiating between non-hypervascular NF-pNENs and SPNs in multivariate logistic regression analysis. The areas under the receiver operating characteristic curves (AUCs) for age, nCTa and nICa in tumour differentiation were 0.855 (95% confidence interval [CI], 0.754–0.956; cutoff, 36 years), 0.797 (95% CI, 0.679–0.916; cutoff, 0.285) and 0.891 (95% CI, 0.806–0.975; cutoff, 0.147), respectively. The combined model (age + nICa) demonstrated the highest performance (AUC = 0.980; 95% CI, 0.952-1.000) when comparing to that of age (P = 0.008), nCTa (P = 0.002) and nICa (P = 0.03), with satisfactory accuracy (92.3%), sensitivity (88.2%) and specificity (100%). The DLCT parameter nICa combined with age facilitates non-invasive quantitative differentiation between non-hypervascular NF-pNENs and SPNs with satisfactory diagnostic performance. Not applicable.

  • Dual-layer spectral detector CT: a non-invasive tool for simultaneously predicting Ki-67 proliferation status and p53 mutations in pancreatic ductal adenocarcinoma

    by Jiaxin Yuan, Jiawei Liu, Mingjie Chen, Yangdi Wang, Minghao Zhang, Liqin Wang, Zhenpeng Peng, Luyong Wei, Siya Shi, Yanji Luo

    Objectives To evaluate the value of dual-layer spectral detector CT (DLCT) for predicting Ki-67 proliferation status and p53 mutations in pancreatic ductal adenocarcinoma (PDAC). Materials & methods This retrospective study included untreated patients with pathologically confirmed PDAC who underwent DLCT between June 2019 and September 2023. Independent relevant clinical-radiological features and quantitative parameters for predicting Ki-67 proliferation status and p53 mutations were identified using multivariate logistic regression analysis. The diagnostic performances of independent variables were evaluated using receiver operating characteristic curves. Results We included 92 patients (60.19 ± 11.22 years old, 61 males). There were 40 patients with high Ki-67 expression (Ki-67 ≥ 25%) and 43 patients positive for p53 mutation. The radiologists showed substantial or near-perfect inter- and intra-observer agreement in evaluating quantitative parameters. Normalised iodine concentration in the arterial phase (nICa) was the only independent predictor of Ki-67 proliferation status (p < 0.001; adjusted odds ratio [OR], 2.33; 95% confidence interval [CI]: 1.46, 3.74; cut-off, 0.0910) and p53 mutations (p < 0.001; adjusted OR, 1.35; 95% CI: 1.07, 1.71; cut-off, 0.0905) according to the multivariate logistic analysis. nICa showed satisfactory performance when using the chosen rounded cut-off value of 0.090 (easily applicable in clinical practice) in predicting Ki-67 proliferation (area under the receiver operating characteristic curve [AUC], 0.812; sensitivity, 87.5%; specificity, 75.0%) and p53 mutations (AUC, 0.731; sensitivity, 76.7%; specificity, 69.4%). Conclusion The DLCT parameter nICa enables simultaneous and non-invasive prediction of both Ki-67 proliferation status and p53 mutations in PDAC with satisfactory diagnostic efficacy.


  • Open Access

    Development and validation of a deep learning radiomics model with clinical-radiological characteristics for the identification of occult peritoneal metastases in patients with pancreatic ductal adenocarcinoma

    by Siya Shi, Chuxuan Lin, Jian Zhou, Luyong Bs Wei, Mingjie Bs Chen, Jian Zhang, Kangyang Cao, Yaheng Fan, Bingsheng Huang, Yanji Luo, et al.

    Background: Occult peritoneal metastases (OPM) in patients with pancreatic ductal adenocarcinoma (PDAC) are frequently overlooked during imaging. The authors aimed to develop and validate a computed tomography (CT)-based deep learning-based radiomics (DLR) model to identify OPM in PDAC before treatment. Methods: This retrospective, bicentric study included 302 patients with PDAC (training: n=167, OPM-positive, n=22; internal test: n=72, OPM-positive, n=9: external test, n=63, OPM-positive, n=9) who had undergone baseline CT examinations between January 2012 and October 2022. Handcrafted radiomics (HCR) and DLR features of the tumor and HCR features of peritoneum were extracted from CT images. Mutual information and least absolute shrinkage and selection operator algorithms were used for feature selection. A combined model, which incorporated the selected clinical-radiological, HCR, and DLR features, was developed using a logistic regression classifier using data from the training cohort and validated in the test cohorts. Results: Three clinical-radiological characteristics (carcinoembryonic antigen 19-9 and CT-based T and N stages), nine HCR features of the tumor, 14 DLR features of the tumor, and three HCR features of the peritoneum were retained after feature selection. The combined model yielded satisfactory predictive performance, with an area under the curve (AUC) of 0.853 (95% CI: 0.790–0.903), 0.845 (95% CI: 0.740–0.919), and 0.852 (95% CI: 0.740–0.929) in the training, internal test, and external test cohorts, respectively (all PPP<0.05) cohorts. The decision curves revealed that the combined model had greater clinical applicability than the clinical-radiological model. Conclusions: The model combining CT-based DLR and clinical-radiological features showed satisfactory performance for predicting OPM in patients with PDAC.


  • Dual-energy CT improves differentiation of non-hypervascular pancreatic neuroendocrine neoplasms from CA 19-9-negative pancreatic ductal adenocarcinomas

    by Xuefang Hu, Siya Shi, Yangdi Wang, Jiaxin Yuan, Mingjie Chen, Luyong Wei, Weiwei Deng, Shi-Ting Feng, Zhenpeng Peng, Yanji Luo

    Purpose To evaluate the utility of dual-energy CT (DECT) in differentiating non-hypervascular pancreatic neuroendocrine neoplasms (PNENs) from pancreatic ductal adenocarcinomas (PDACs) with negative carbohydrate antigen 19–9 (CA 19-9). Methods This retrospective study included 26 and 39 patients with pathologically confirmed non-hypervascular PNENs and CA 19-9-negative PDACs, respectively, who underwent contrast-enhanced DECT before treatment between June 2019 and December 2021. The clinical, conventional CT qualitative, conventional CT quantitative, and DECT quantitative parameters of the two groups were compared using univariate analysis and selected by least absolute shrinkage and selection operator regression (LASSO) analysis. Multivariate logistic regression analyses were performed to build qualitative, conventional CT quantitative, DECT quantitative, and comprehensive models. The areas under the receiver operating characteristic curve (AUCs) of the models were compared using DeLong’s test. Results The AUCs of the DECT quantitative (based on normalized iodine concentrations [nICs] in the arterial and portal venous phases: 0.918; 95% confidence interval [CI] 0.852–0.985) and comprehensive (based on tumour location and nICs in the arterial and portal venous phases: 0.966; 95% CI 0.889–0.995) models were higher than those of the qualitative (based on tumour location: 0.782; 95% CI 0.665–0.899) and conventional CT quantitative (based on normalized conventional CT attenuation in the arterial phase: 0.665; 95% CI 0.533–0.797; all P < 0.05) models. The DECT quantitative and comprehensive models had comparable performances (P = 0.076). Conclusions Higher nICs in the arterial and portal venous phases were associated with higher blood supply improving the identification of non-hypervascular PNENs.